TRAF6 and cancer: Tumor cells overexpressing TRAF6 produce proteins that promote cell growth and survival while meanwhile inhibiting the mechanisms of cell death, and thus, it represents a potential therapeutic target for the treatment of cancer through inhibition of UPS TRAF6-mediated K63-linked polyubiquitination as a means to shift this fine equilibrium towards cell death [5, 13].